Elevation Point Wealth Partners LLC bought a new stake in shares of HealthEquity, Inc. (NASDAQ:HQY – Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 5,836 shares of the company’s stock, valued at approximately $488,000.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Fifth Third Wealth Advisors LLC grew its stake in shares of HealthEquity by 4.2% in the 1st quarter. Fifth Third Wealth Advisors LLC now owns 2,872 shares of the company’s stock worth $240,000 after buying an additional 116 shares during the last quarter. Truist Financial Corp boosted its holdings in HealthEquity by 4.9% in the fourth quarter. Truist Financial Corp now owns 2,537 shares of the company’s stock worth $232,000 after acquiring an additional 119 shares in the last quarter. Fiduciary Trust Co boosted its holdings in HealthEquity by 3.4% in the third quarter. Fiduciary Trust Co now owns 3,669 shares of the company’s stock worth $348,000 after acquiring an additional 120 shares in the last quarter. Larson Financial Group LLC grew its stake in shares of HealthEquity by 24.4% in the third quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock worth $60,000 after acquiring an additional 123 shares during the last quarter. Finally, GAMMA Investing LLC grew its stake in shares of HealthEquity by 9.5% in the fourth quarter. GAMMA Investing LLC now owns 1,944 shares of the company’s stock worth $178,000 after acquiring an additional 168 shares during the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.
HealthEquity Price Performance
HQY opened at $94.73 on Thursday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 3.44 and a current ratio of 3.44. The stock has a market capitalization of $7.92 billion, a P/E ratio of 35.48, a P/E/G ratio of 1.63 and a beta of 0.21. The company’s 50-day simple moving average is $86.93 and its two-hundred day simple moving average is $84.60. HealthEquity, Inc. has a 52-week low of $72.76 and a 52-week high of $105.96.
Analyst Ratings Changes
HQY has been the topic of several recent analyst reports. Deutsche Bank Aktiengesellschaft increased their price objective on shares of HealthEquity from $120.00 to $128.00 and gave the company a “buy” rating in a research report on Thursday, March 19th. Citizens Jmp upped their target price on shares of HealthEquity from $110.00 to $111.00 and gave the stock a “market outperform” rating in a research note on Monday, June 1st. Royal Bank Of Canada increased their price target on shares of HealthEquity from $100.00 to $108.00 and gave the company an “outperform” rating in a report on Wednesday, June 3rd. JPMorgan Chase & Co. reduced their price target on shares of HealthEquity from $129.00 to $123.00 and set an “overweight” rating for the company in a research report on Wednesday, March 18th. Finally, Barrington Research restated an “outperform” rating and issued a $110.00 price objective on shares of HealthEquity in a report on Friday, May 22nd. Eleven analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $110.57.
Check Out Our Latest Research Report on HealthEquity
Insider Buying and Selling
In related news, EVP Delano Ladd sold 7,500 shares of the company’s stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total transaction of $675,000.00. Following the completion of the sale, the executive vice president owned 91,141 shares in the company, valued at approximately $8,202,690. This represents a 7.60% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 2,470 shares of the firm’s stock in a transaction dated Thursday, July 2nd. The stock was sold at an average price of $95.00, for a total value of $234,650.00. Following the completion of the transaction, the executive vice president directly owned 56,643 shares in the company, valued at $5,381,085. The trade was a 4.18% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 15,551 shares of company stock valued at $1,427,650 over the last 90 days. Company insiders own 1.60% of the company’s stock.
About HealthEquity
HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.
Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.
Featured Stories
- Five stocks we like better than HealthEquity
- A Market Panic Just Discounted the AI Highway’s Tollbooth
- Why Exxon Could Be the Market’s Next Big Comeback Stock
- The Market Just Got Shaken—These 3 ETFs May Come Out Stronger
- Meta Platforms’ Cloud Push: Growth Opportunity Versus AI Concerns
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
